These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32868048)

  • 1. Commentary: The high cost of low output.
    Serna-Gallegos D; Sultan I
    J Thorac Cardiovasc Surg; 2022 May; 163(5):1899-1900. PubMed ID: 32868048
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: The high cost of low output.
    Eikelboom R; Arora RC
    J Thorac Cardiovasc Surg; 2022 May; 163(5):1900-1901. PubMed ID: 32896375
    [No Abstract]   [Full Text] [Related]  

  • 3. How can a cost/benefit ratio be optimized for an output measurement program of external photon radiotherapy beams?
    Kapanen M; Bly R; Sipilä P; Järvinen H; Tenhunen M
    Phys Med Biol; 2011 Apr; 56(7):2119-30. PubMed ID: 21389356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on: A cost-effectiveness analysis of onabotulinumtoxin A as first-line treatment for overactive bladder.
    Abdelrahman A
    Int Urogynecol J; 2018 Aug; 29(8):1221. PubMed ID: 29705836
    [No Abstract]   [Full Text] [Related]  

  • 5. Preconditioning with levosimendan reduces postoperative low cardiac output in moderate-severe systolic dysfunction patients who will undergo elective coronary artery bypass graft surgery: a cost-effective strategy.
    Jiménez-Rivera JJ; Álvarez-Castillo A; Ferrer-Rodríguez J; Iribarren-Sarrías JL; García-González MJ; Jorge-Pérez P; Lacalzada-Almeida J; Pérez-Hernández R; Montoto-López J; Martínez-Sanz R
    J Cardiothorac Surg; 2020 May; 15(1):108. PubMed ID: 32448319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: Cost-Benefit Analysis of Transitional Care in Neurosurgery.
    Dagenais S
    Neurosurgery; 2019 Nov; 85(5):E837-E838. PubMed ID: 30476317
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on Zur & Zaric and Shepard et al. (2016): Cost-effectiveness of SBI for alcohol--where are we and where do we want to go?
    Barbosa C; Cowell A
    Addiction; 2016 May; 111(5):840-2. PubMed ID: 27060581
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost benefit and cost effectiveness analysis: a bibliography for pharmacists.
    Lunik MC; Segal R
    Hosp Pharm; 1986 Nov; 21(11):1072-5. PubMed ID: 10311748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary: prevention and cost of asthma--a model for cost effective health care.
    Cohn JR; Caliguiri LA; Gallagher PE; Schenkel EJ
    Allergy Proc; 1994; 15(1):39-41. PubMed ID: 8005455
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on 'Cost-effectiveness of Screening for Abdominal Aortic Aneurysm in Combination with Medical Intervention in Patients with Small Aneurysms'.
    Brunkwall JS; Brunkwall SK
    Eur J Vasc Endovasc Surg; 2016 Jun; 51(6):774. PubMed ID: 27116912
    [No Abstract]   [Full Text] [Related]  

  • 11. Trying to do better than average: a commentary on 'statistical inference for cost-effectiveness ratios'.
    Briggs A; Fenn P
    Health Econ; 1997; 6(5):491-5. PubMed ID: 9353649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: Surgical Management of the Elderly With Traumatic Cervical Spinal Cord Injury: A Cost-Utility Analysis.
    Babu MA
    Neurosurgery; 2016 Sep; 79(3):426-7. PubMed ID: 27409406
    [No Abstract]   [Full Text] [Related]  

  • 13. What a physician needs to know about cost-effectiveness: commentary.
    Cheitlin MD
    Cardiol Rev; 2000; 8(2):103. PubMed ID: 11174881
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary on "critical appraisal of published systematic reviews assessing the cost-effectiveness of telemedicine studies".
    Bashshur RL; Reardon TG
    Telemed J E Health; 2014 Sep; 20(9):883-4. PubMed ID: 25184946
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary. Mental health at a reasonable cost.
    Miller MC
    Harv Ment Health Lett; 2009 Feb; 25(8):8. PubMed ID: 19241618
    [No Abstract]   [Full Text] [Related]  

  • 16. Capsule Commentary on Phibbs et. al., At-Home versus In-Clinic INR Monitoring: A Cost-Utility Analysis from The Home INR Study (THINRS).
    Canestaro WJ
    J Gen Intern Med; 2016 Sep; 31(9):1082. PubMed ID: 27216482
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness of migraine treatment: a commentary.
    Smith DG
    Value Health; 2003; 6(4):436-7. PubMed ID: 12859584
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary on: Cost-Utility Analysis of Surgical Decompression Relative to Injection Therapy for Chronic Migraine Headaches.
    Amirlak B; Chung MH; Masrour S
    Aesthet Surg J; 2019 Nov; 39(12):NP471-NP473. PubMed ID: 31504133
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial Commentary: Cost-Effectiveness of Orthopaedic Procedures: "A Nickel Ain't Worth a Dime Anymore" - Yogi Berra.
    Higgins LD
    Arthroscopy; 2016 Sep; 32(9):1781-3. PubMed ID: 27594328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on Vemer et al. (2010): when is smoking cessation really cost-effective?
    Salize HJ
    Addiction; 2010 Jun; 105(6):1098-9. PubMed ID: 20659064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.